Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
Clinical trial NCT04708834 · TERMINATED
Trial details
- NCT number
- NCT04708834
- Sponsor
- Biohaven Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-30
- Primary completion
- 2026-02-13
- Enrollment
- 772
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.